法拉第未来宣布通过 PIPE 投资 4,100 万美元入股 Qualigen Therapeu...

Core Viewpoint - Faraday Future (NASDAQ: FFAI) announced a PIPE investment of approximately $41 million in Qualigen Therapeutics (NASDAQ: QLGN), which will rebrand to CXC10 and focus on the crypto and Web3 ecosystem after the transaction [1] Investment Details - The investment will result in FFAI and its founder Jia Yueting holding over 62% of the shares combined, with Jia personally investing $4 million and committing to a two-year lock-up period [1] - Faraday Future's President Jerry Wang will become Co-CEO of QLGN, while CFO Koti Meka will take on the CFO role [1] Strategic Partnerships - The investment is supported by Binance Labs and other participants from the SIGN Foundation [1]